Description
Anti Human IgE Antibody (Epsilon Chain Specific) Conjugated to FITC
| Catalog number: | B2010785 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.5 mg |
| Molecular Weight or Concentration: | na |
| Supplied as: | Lyophilized |
| Applications: | multipurpose antibody for various assay formats, including ELISA |
| Storage: | -20C |
| Keywords: | anti-IgE FITC, Epsilon specific anti-IgE FITC, anti-IgE Epsilon FITC |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Poms A, Mueller GA, Chruszcz M. Structural Aspects of the Allergen-Antibody Interaction Front Immunol. 2020 Sep 2;11:2067.
- DAmato G. Therapy of allergic bronchial asthma with omalizumab an anti-IgE monoclonal antibody Expert Opin Biol Ther. 2003 Apr;3(2):371-6.
- Guntern P, Eggel A. Past, present, and future of anti-IgE biologics Allergy. 2020 Oct;75(10):2491-2502.
- Cohen ES, Dobson CL, Kck H, Wang B, Sims DA, Lloyd CO, England E, Rees DG, Guo H, Karagiannis SN, OBrien S, Persdotter S, Ekdahl H, Butler R, Keyes F, S, Carlsson M, Briend E, Wilkinson T, Anderson IK, Monk PD, von Wachenfeldt K, Eriksson PO, Gould HJ, Vaughan TJ, May RD. A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma MAbs. 2014 May-Jun;6(3):756-64.
- Nyborg AC, Zacco A, Ettinger R, Jack Borrok M, Zhu J, Martin T, Woods R, Kiefer C, Bowen MA, Suzanne Cohen E, Herbst R, Wu H, Coats S. Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells Cell Mol Immunol. 2016 May;13(3):391-400.
- Chung KF. Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthma Expert Opin Pharmacother. 2004 Feb;5(2):439-46.
- Scheinfeld N. Omalizumab: a recombinant humanized monoclonal IgE-blocking antibody Dermatol Online J. 2005 Mar 1;11(1):2.
- Ruffin CG, Busch BE. Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma Am J Health Syst Pharm. 2004 Jul 15;61(14):1449-59.
- Logsdon SL, Oettgen HC. Anti-IgE therapy: clinical utility and mechanistic insights Curr Top Microbiol Immunol. 2015;388:39-61.
